Lion Point Capital, LP

Q2 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
35
Total value ($000)
$20,905
Net value change ($000)
+4,173 (24.9%)
New positions
1
Sold out positions
1
Turnover %
10.4%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
CUE BIOPHARMA INC 1,670 NEW
CMPS 690 156.1%
FENC 518 75.0%
QURE 437 182.1%
BHVN 332 76.0%
LNTH 193 46.3%
RPRX 173 16.8%
BNTC 170 25.8%
GHRS 131 91.6%
KURA 131 35.0%
Top Reduces (Value $000, Stocks/ETFs)
CUE -506 -100.0%
JSPR -211 -51.8%
GERN -121 -14.1%
ARDX -115 -14.9%
SRPT -108 -17.4%
SNDX -54 -6.4%
MCRB -31 -11.1%
RCKT -14 -4.5%
SPRB -11 -16.9%
INVA -5 -2.6%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type